Sofosbuvir (Sovaldi) Approved in USA

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.

CNN: “The U.S. Food and Drug Administration approved a breakthrough drug Friday to treat chronic hepatitis C virus infection. Sovaldi (sofosbuvir) is the first drug that has been shown to safely and effectively treat certain types of hepatitis C infection without a need for interferon, the FDA said.”
Read more…http://edition.cnn.com/2013/12/06/health/fda-hepatitis-c/index.html?hpt=hp_t4

Leave a Reply